| P2093 | author name string | Paul J Fairchild | |
| | Ashleigh S Boyd | |
| P2860 | cites work | Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype | Q24293121 |
| | Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1 | Q24300625 |
| | Prevention of allogeneic fetal rejection by tryptophan catabolism | Q24336018 |
| | Disease-specific induced pluripotent stem cells | Q24641981 |
| | Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. | Q24655516 |
| | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 |
| | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
| | Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 |
| | Establishment in culture of pluripotential cells from mouse embryos | Q27860625 |
| | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
| | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 |
| | Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 |
| | Expression of programmed death 1 ligands by murine T cells and APC | Q28214264 |
| | Sheep cloned by nuclear transfer from a cultured cell line | Q28275874 |
| | 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation | Q28370605 |
| | Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 |
| | A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism | Q29614266 |
| | Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells | Q38304430 |
| | Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo | Q39823115 |
| | Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells | Q39856765 |
| | Directed differentiation of human-induced pluripotent stem cells generates active motor neurons | Q39863440 |
| | The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury | Q40025597 |
| | Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack | Q40083810 |
| | Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function | Q40095781 |
| | Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells | Q40229749 |
| | Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. | Q40395995 |
| | Embryonic stem cells: a novel source of dendritic cells for clinical applications. | Q40482532 |
| | Human embryonic stem cells possess immune-privileged properties | Q40531152 |
| | Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro | Q40537295 |
| | Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 |
| | Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes | Q40722072 |
| | NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance | Q40723327 |
| | Surface antigens of human embryonic stem cells: changes upon differentiation in culture | Q40729324 |
| | Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy | Q40738121 |
| | Hepatic maturation in differentiating embryonic stem cells in vitro | Q40803055 |
| | Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. | Q40809607 |
| | Directed differentiation of dendritic cells from mouse embryonic stem cells. | Q40837850 |
| | Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. | Q40876310 |
| | Generation of purified neural precursors from embryonic stem cells by lineage selection | Q41008017 |
| | Central tolerance of T cells | Q41098056 |
| | Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon | Q41815168 |
| | Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters | Q41829327 |
| | Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 |
| | Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells | Q42793227 |
| | Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells | Q42984504 |
| | Human embryonic stem cell (hES) derived dendritic cells are functionally normal and are susceptible to HIV-1 infection | Q43052736 |
| | Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells | Q43224014 |
| | Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells | Q44485559 |
| | Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation | Q44786842 |
| | Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells | Q45345520 |
| | Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction | Q45880435 |
| | Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. | Q45948061 |
| | GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. | Q46490849 |
| | Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats | Q47795541 |
| | Neural progenitor cells lack immunogenicity and resist destruction as allografts. | Q47795672 |
| | Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta | Q48498169 |
| | The immune system and the nervous system | Q48852534 |
| | The blood-brain barrier protects foreign antigens in the brain from immune attack | Q49013222 |
| | Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. | Q50616625 |
| | Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 |
| | Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions. | Q51948437 |
| | Immunosuppression by embryonic stem cells. | Q51970329 |
| | Lymphopenia-driven CD8(+) T cells are resistant to antigen-induced tolerance in NOD.scid mice. | Q51981243 |
| | Involution and cystic transformation of the thymus in the bottlenose dolphin, Tursiops truncatus. | Q53154840 |
| | Costimulation blockade induces tolerance to HESC transplanted to the testis and induces regulatory T-cells to HESC transplanted into the heart. | Q53478474 |
| | Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells. | Q53503551 |
| | Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. | Q53588370 |
| | Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. | Q53722655 |
| | Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells. | Q53949587 |
| | Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. | Q54645452 |
| | A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells | Q56765649 |
| | Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells | Q57702466 |
| | A role for CD95 ligand in preventing graft rejection | Q59066471 |
| | Foxp3-dependent programme of regulatory T-cell differentiation | Q59084714 |
| | Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes | Q29614341 |
| | Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 |
| | Induced pluripotent stem cells generated without viral integration | Q29614343 |
| | Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts | Q29614794 |
| | Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 |
| | Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons | Q29616199 |
| | An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 |
| | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 |
| | Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 |
| | Generation of induced pluripotent stem cells using recombinant proteins | Q29619162 |
| | Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin | Q29619238 |
| | The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 |
| | A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 |
| | piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells | Q29619409 |
| | Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid | Q29619479 |
| | CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 |
| | Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. | Q30489278 |
| | Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds | Q33382569 |
| | Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner | Q33438830 |
| | Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen | Q33499668 |
| | Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders | Q33560423 |
| | Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells | Q33591090 |
| | Reprogramming of pancreatic beta cells into induced pluripotent stem cells | Q33641629 |
| | The immunology of pregnancy | Q33710909 |
| | Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? | Q33740214 |
| | Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. | Q33763653 |
| | Marrow stromal stem cells | Q33947769 |
| | Dendritic cells and prospects for transplantation tolerance | Q34046816 |
| | Characterization of the expression of MHC proteins in human embryonic stem cells | Q34076010 |
| | Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo | Q34131812 |
| | Adult frogs derived from the nuclei of single somatic cells | Q34252349 |
| | Designer dendritic cells for tolerance induction: guided not misguided missiles | Q34319943 |
| | Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts | Q34387398 |
| | Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. | Q34550440 |
| | Generation and regulation of CD8(+) regulatory T cells | Q34602623 |
| | Thymic output in aged mice | Q34694301 |
| | "Infectious" transplantation tolerance. | Q34726892 |
| | Generation of pluripotent stem cells from adult mouse liver and stomach cells | Q34750323 |
| | Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency | Q34771507 |
| | Immature, but not inactive: the tolerogenic function of immature dendritic cells | Q34842360 |
| | Oct4-induced pluripotency in adult neural stem cells. | Q34940495 |
| | Variation in the safety of induced pluripotent stem cell lines | Q34991636 |
| | Hazardous crossing: immunosuppression and nosocomial infections in solid organ transplant recipients | Q35069193 |
| | Immunoregulation in the tissues by gammadelta T cells | Q35092547 |
| | Molecular complexities of stem cells | Q35104927 |
| | Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells | Q35117509 |
| | The immune privilege of corneal grafts | Q35186805 |
| | The Hair Follicle and Immune Privilege | Q35569804 |
| | Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy | Q35762417 |
| | The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective. | Q35791048 |
| | Novel strategies for steroid-refractory acute graft-versus-host disease | Q35987086 |
| | Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. | Q36107275 |
| | Tissue expression of PD-L1 mediates peripheral T cell tolerance. | Q36228541 |
| | Homeostatic T cell proliferation as a barrier to T cell tolerance | Q36251301 |
| | Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation | Q36313586 |
| | Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient | Q36347161 |
| | Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells | Q36370232 |
| | Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. | Q36370461 |
| | Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway | Q36407194 |
| | Immune privilege induced by regulatory T cells in transplantation tolerance | Q36593774 |
| | Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance | Q36693370 |
| | Current concepts and perspectives of immunosuppression in organ transplantation | Q36798362 |
| | Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts | Q36861712 |
| | Genetic modification of dendritic cells through the directed differentiation of embryonic stem cells | Q36944524 |
| | Emerging concepts in CD8(+) T regulatory cells | Q37136267 |
| | Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism | Q37211290 |
| | Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. | Q37211408 |
| | Infectious tolerance via the consumption of essential amino acids and mTOR signaling | Q37246191 |
| | Generation of pluripotent stem cells from patients with type 1 diabetes | Q37327472 |
| | Functional cardiomyocytes derived from human induced pluripotent stem cells | Q37341034 |
| | TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes | Q37358159 |
| | Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration | Q37537193 |
| | Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells | Q37704797 |
| P433 | issue | 3 | |
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 435-448 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Expert Review of Clinical Immunology | Q15733763 |
| P1476 | title | Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies | |
| P478 | volume | 6 | |